NANOGEN | Solution for infusion Mannitol 20%

NANOGEN | Solution for infusion Mannitol 20%

NANOGEN | Solution for infusion Mannitol 20%

NANOGEN | Solution for infusion Mannitol 20%

NANOGEN | Solution for infusion Mannitol 20%

MANNITOL 20%

MANNITOL 20%

COMPOSITION
Active ingredient: Mannitol 20% (w/v)
Excipients: Hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment), water for injection.
PHARMACEUTICAL FORM
Solution for infusion
A clear, colourless solution, no strange particles, packed in colourless plastic bottle. Mannitol crystals may form during storage.
Osmolarity: 1098 mOsmol/L
pH: 4,5 – 7,0
THERAPEUTIC INDICATIONS
  • Intracranial pressure and treatment of cerebral edema; 
  • Elevated intraocular pressure.
CONTRAINDICATIONS 
Mannitol Injection is contraindicated in patients with: 
  • Known hypersensitivity to mannitol;
  • Anuria;
  • Severe hypovolemia;
  • Pre-existing pulmonary vascular congestion or pulmonary edema;
  • Active intracranial bleeding except during craniotomy.
PACKAGING SPECIFICATIONS
Box of 24 vials x 250 mL, box of 12 vials x 500 mL.
STORAGE CONDITIONS, EXPIRATION DATE, QUALITY STANDARDS
Storage conditions: Store in a cool, dry place at a temperature not exceeding 30°C, protect from light.
Expiration date: 3 years from manufacturing date.
Specification: USP.
MANUFACTURING FACILITY
NANOGEN LAM DONG PHARMACEUTICAL MANUFACTURING CO., LTD.
BII-11-KCN; BII-12-KCN; BII-13-KCN; BII-14-KCN at Phu Hoi Industrial Zone, Phu Hoi Commune, Duc Trong District, Lam Dong Province, Vietnam

Related products

Current product

PACEPHENE

Upcoming product

MOCIN

Current product

GLUCONA